| Name | Title | Contact Details |
|---|---|---|
Deirdre Murtagh |
Vice President R&D Finance | Profile |
James Rutigliano |
Director, R&D Quality Assurance | Profile |
Laszlo Romoda |
Director, Product Development, Device R&D | Profile |
Anju Starace |
Associate Vice President, Dedicated Project Leader, R&D Project and Portfolio Management | Profile |
Agnieszka Zak |
R&D Project and Portfolio Associate Director | Profile |
GTC Biotherapeutics is a Framingham, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Armata is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology.
ImmPACT-Bio is pioneering a novel strategy to surmount a major challenge compromising current Chimeric Antigen Receptor T-cell (CAR-T) therapy. Our technology addresses the need to differentiate cancerous from non-cancerous tissues impacting the safety of the treatment which is to date a major limitation in reaching effectiveness.
Point Medical Corporation is a Crown Point, IN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
AnaSpec, EGT Group is a leading provider of integrated proteomics and genomics solution for worldwide life science research. AnaSpec offers expertise in peptides, detection reagents, antibodies, assay kits, amino acids, oligonucleotides, and qPCR. AnaSpec carries a broad product line of biochemicals and reagents for basic research, high-throughput screening and drug discovery. AnaSpec also provides premier custom services including peptide synthesis, antibody production, assay development, fluorescent dyes, and oligonucleotide synthesis.